Journal Article DZNE-2021-00866

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Optimized Adeno-Associated Virus Vectors for Efficient Transduction of Human Retinal Organoids.

 ;  ;  ;  ;

2021
Liebert New York, NY

Human gene therapy 32(13-14), 694 - 706 () [10.1089/hum.2020.321]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: The most widely used vectors for gene delivery in the retina are recombinant adeno-associated virus (rAAV) vectors. They have proven to be safe and effective in retinal gene therapy studies aimed to treat inherited retinal dystrophies, although with various limitations in transduction efficiency. Novel variants with modified capsid sequences have been engineered to improve transduction and overcome limitations of naturally occurring variants. Although preclinical evaluation of rAAV vectors based on such novel capsids is mostly done in animal models, the use of human induced pluripotent stem cell (hiPSC)-derived organoids offers an accessible and abundant human testing platform for rAAV evaluation. In this study, we tested the novel capsids, AAV9.GL and AAV9.NN, for their tropism and transduction efficiency in hiPSC-derived human retinal organoids (HROs) with all major neuronal and glial cell types in a laminated structure. These variants are based on the AAV9 capsid and were engineered to display specific surface-exposed peptide sequences, previously shown to improve the retinal transduction properties in the context of AAV2. To this end, HROs were transduced with increasing concentrations of rAAV9, rAAV9.GL, or rAAV9.NN carrying a self-complementary genome with a cytomegalovirus-enhanced green fluorescent protein (eGFP) cassette and were monitored for eGFP expression. The rAAV vectors transduced HROs in a dose-dependent manner, with rAAV9.NN achieving the highest efficiency and fastest onset kinetics, leading to detectable eGFP signals in photoreceptors, some interneurons, and Müller glia already at 2 days post-transduction. The potency-enhancing effect of the NN peptide insert was replicated when using the corresponding AAV2-based version (rAAV2.NN). Taken together, we report the application of an HRO system for screening novel AAV vectors and introduce novel vector candidates with enhanced transduction efficiency for human retinal cells.

Keyword(s): Animals (MeSH) ; Dependovirus: genetics (MeSH) ; Gene Transfer Techniques (MeSH) ; Genetic Vectors: genetics (MeSH) ; Green Fluorescent Proteins: genetics (MeSH) ; Humans (MeSH) ; Induced Pluripotent Stem Cells (MeSH) ; Organoids (MeSH) ; Retina (MeSH) ; Transduction, Genetic (MeSH) ; adeno-associated virus ; engineered AAV vector ; human retinal organoids

Classification:

Contributing Institute(s):
  1. Retinal Regeneration and Degeneration (AG Karl)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Appears in the scientific report 2021
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > DD DZNE > DD DZNE-AG Karl
Public records
Publications Database

 Record created 2021-09-02, last modified 2023-09-15



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)